PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.01%
Growth of 1.01% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
51.22%
Cost growth of 51.22% versus flat Healthcare costs. Walter Schloss would verify cost control.
-129.16%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-128.87%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
3.64%
R&D change of 3.64% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-6.41%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
-24.16%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-1.99%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-8.97%
Operating expenses reduction while Healthcare median is -0.97%. Seth Klarman would investigate advantages.
24.32%
Total costs growth while Healthcare reduces costs. Peter Lynch would examine differences.
-66.53%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
1.35%
D&A change of 1.35% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
-2230.01%
EBITDA decline while Healthcare median is 2.55%. Seth Klarman would investigate causes.
-37.31%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-2648.08%
Operating income decline while Healthcare median is 2.72%. Seth Klarman would investigate causes.
-2620.65%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
100.80%
Other expenses growth exceeding 1.5x Healthcare median of 0.58%. Jim Chanos would check for issues.
-1544.98%
Pre-tax income decline while Healthcare median is 3.18%. Seth Klarman would investigate causes.
-1528.57%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
7.70%
Tax expense change of 7.70% versus flat Healthcare. Walter Schloss would verify strategy.
-1840.05%
Net income decline while Healthcare median is 3.71%. Seth Klarman would investigate causes.
-1820.69%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1840.00%
EPS decline while Healthcare median is 6.58%. Seth Klarman would investigate causes.
-1840.00%
Diluted EPS decline while Healthcare median is 6.97%. Seth Klarman would investigate causes.
0.63%
Share count reduction below 50% of Healthcare median of 0.21%. Jim Chanos would check for issues.
0.63%
Diluted share reduction below 50% of Healthcare median of 0.20%. Jim Chanos would check for issues.